Immunostimulatory activity of protein hydrolysate from oviductus ranae on macrophage in vitro

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Huang, Di ^a   Yang, Lubing ^a   Wang, Chenlu ^a   Ma, Sihui ^a   Cui, Li ^a   Huang, Shiyang ^a   Sheng, Xia ^a   Weng, Qiang ^a   Xu, Meiyu ^a  

^a BEIJING FORESTRY UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PROTEINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSTIMULATING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NEUTRAL PROTEINASE; NITRIC OXIDE; PAPAIN; PEPSIN A; PROTEIN HYDROLYSATE; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CELLULAR IMMUNITY; CHINESE MEDICINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HYDROLYSIS; IMMUNOSTIMULATION; IN VITRO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOLECULAR WEIGHT; NONHUMAN; OVIDUCTUS RANAE; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RANA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84920506881     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/180234     Document Type: Article

References (42)

1. M. Cutolo, "Macrophages as effectors of the immunoendocrinologic interactions in autoimmune rheumatic diseases," Annals of the New York Academy of Sciences, vol. 876, no. 1, pp. 32-42, 1999
2. S. B. Gordon and R. C. Read, "Macrophage defences against respiratory tract infections," BritishMedical Bulletin, vol. 61, no. 1, pp. 45-61, 2002.
3. S. B. Han, Y. D. Yoon, H. J. Ahn et al., "Toll-like receptormediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus," International Immunopharmacology, vol. 3, no. 9, pp. 1301-1312, 2003.
4. A. Tada, Y. Kaneiwa, J. Shoji, and S. Shibata, "Studies on the saponins of the root of Platycodon grandiflorum A. De Candolle. I. Isolation and the structure of platycodin-D," Chemical and Pharmaceutical Bulletin, vol. 23, no. 11, pp. 2965-2972, 1975.
5. K. S. Kim,O.Ezaki, S. Ikemoto, andH. Itakura, "EffectsofPlatycodon grandiflorum feeding on serum and liver lipid concentrations in rats with diet-induced hyperlipidemia," Journal of Nutritional Science and Vitaminology, vol. 41,no. 4, pp. 485-491, 1995.
6. S. Singh and A. K. Gupta, "Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies," Cancer Chemotherapy and Pharmacology, vol. 67, no. 6, pp. 1211-1224, 2011.
7. C. V. Rao, "Nitric oxide signaling in colon cancer chemoprevention," Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 555, no. 1-2, pp. 107-119, 2004.
8. F. R. Balkwill, M. S. Naylor, and S. Malik, "Tumour necrosis factor as an anticancer agent," European Journal of Cancer, vol. 26, no. 5, pp. 641-644, 1990.
9. E. H. Han, J. H. Choi, Y. P. Hwang et al., "Immunostimulatory activity of aqueous extract isolated fromPrunella vulgaris," Food and Chemical Toxicology, vol. 47, no. 1, pp. 62-69, 2009.
10. Z. Zhang, B. Zhang, X. Nie, Q. Liu, F. Xie, and D. Shang, "Transcriptome analysis and identification of genes related to immune function in skin of the chinese brown frog," Zoological Science, vol. 26, no. 1, pp. 80-86, 2009.
11. Y. Shen, Y. Liu, J. Ma et al., "Immunoreactivity of c-kit receptor protein during the prehibernation period in the oviduct of the Chinese brown frog, Rana chensinensis," The Journal of Veterinary Medical Science, vol. 74, no. 2, pp. 209-213, 2012.
12. The State Pharmacopoeia Commission of the Peoples Republic of China, Pharmacopoeia of the Peoples Republic of China: Oviductus Ranae, Chemical Industry Press, Beijing, China, 2005.
13. M. Zhang, Y. Li, B. Yao et al., "Transcriptome sequencing and de novo analysis for Oviductus Ranae of Rana chensinensis using illumina RNA-Seq technology," Journal of Genetics and Genomics, vol. 40, no. 3, pp. 137-140, 2013.
14. Y.Xuegan,W. Yiquan,Z.Kaiya, andL. Zhongquan, "Authentication of oviductus ranae and its original animals using molecular marker," Biological and Pharmaceutical Bulletin, vol. 25, no. 8, pp. 1035-1039, 2002.
15. F. Gao,H. Y. Zhang, K. Zhang et al., "Astudy onhealth functions of oviductus ranae," Chinese Journal Public Health, vol. 21, no. 1, pp. 9-10, 2005.
16. X. Li, Y. Su, J. Sun, and Y. Yang, "Chicken embryo extracts enhance spleen lymphocyte and peritoneal macrophages function," Journal of Ethnopharmacology, vol. 144, no. 2,pp. 255-260, 2012.
17. W. Chen, W. Zhang, W. Shen, and K. Wang, "Effects of the acid polysaccharide fraction isolated from a cultivated Cordyceps sinensis on macrophages in vitro,"Cellular Immunology, vol. 262, no. 1, pp. 69-74, 2010.
18. J. He, Y. Wang, L.-H. Xu, J. Qiao, D.-Y. Ouyang, and X.-H. He, "Cucurbitacin IIa induces caspase-3-dependent apoptosis and enhances autophagy in lipopolysaccharide-stimulated RAW 264.7 macrophages," International Immunopharmacology, vol. 16, no. 1, pp. 27-34, 2013.
19. S.Koppula,W.-J. Kim, J. Jiang et al., "Carpesiummacrocephalum attenuates lipopolysaccharide-induced inflammation in macrophages by regulating the NF-B/IB-α, Akt, andSTATsignaling pathways," The American Journal of Chinese Medicine, vol. 41, no. 4, pp. 927-943, 2013.
20. C. Bogdan, "Nitric oxide and the immune response," Nature Immunology, vol. 2, no. 10, pp. 907-916, 2001.
21. J. Léonil, V. Gagnaire, D. Mollé, S. Pezennec, and S. Bouhallab, "Application of chromatography and mass spectrometry to the characterization of food proteins and derived peptides," Journal of Chromatography A, vol. 881, no. 1-2, pp. 1-21, 2000.
22. D. Zhou, L. Qin, B. Zhu et al., "Optimisation of hydrolysis of purple sea urchin (Strongylocentrotus nudus) gonad by response surface methodology and evaluation of in vitro antioxidant activity of the hydrolysate," Journal of the Science of Food and Agriculture, vol. 92, no. 8, pp. 1694-1701, 2012.
23. G. H. Werner, "Natural and synthetic peptides (other than neuropeptides) endowed with immunomodulating activities," Immunology Letters, vol. 16, no. 3-4, pp. 363-370, 1987.
24. H. Hou, Y. Fan, B. Li, C. Xue, and G. Yu, "Preparation of immunomodulatory hydrolysates fromAlaska pollock frame," Journal of the Science of Food and Agriculture, vol. 92, no. 15, pp. 3029- 3038, 2012.
25. K. Hoebe, E. M. Janssen, S. O. Kim et al., "Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trifindependent pathways," Nature Immunology, vol. 4, no. 12, pp. 1223-1229, 2003.
26. S. C. Cheison, Z. Wang, and S.-Y. Xu, "Preparation of whey protein hydrolysates using a single- and two-stage enzymatic membrane reactor and their immunological and antioxidant properties: characterization bymultivariate data analysis," Journal of Agricultural and Food Chemistry, vol. 55, no. 10, pp. 3896- 3904, 2007.
27. S. B. Kim, I. S. Seo, M. A. Khan et al., "Enzymatic hydrolysis of heated whey: iron-binding ability of peptides and antigenic protein fractions," Journal of Dairy Science, vol. 90, no. 9, pp. 4033-4042, 2007.
28. J. Duarte, G. Vinderola, B. Ritz, G. Perdigón, and C. Matar, "Immunomodulating capacity of commercial fish protein hydrolysate for diet supplementation," Immunobiology, vol. 211, no. 5, pp. 341-350, 2006.
29. Y.-K. Wang, H.-L. He, G.-F. Wang et al., "Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice," Marine Drugs, vol. 8, no. 2, pp. 255-268, 2010.
30. L. Gattegno, D. Migliore-Samour, L. Saffar, and P. Jolles, "Enhancement of phagocytic activity of human monocyticmacrocytic cells by immunostimulating peptides from human casein," Immunology Letters, vol. 18, no. 1, pp. 27-31, 1988.
31. G. Vinderola, G. Perdigón, J. Duarte, E. Farnworth, and C. Matar, "Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity," Cytokine, vol. 36, no. 5-6, pp. 254-260, 2006.
32. M. Okada, M. Kitahara, S. Kishimoto, T. Matsuda, T. Hirano, and T. Kishimoto, "IL-6/BSF-2 functions as a killer helper factorin the in vitro induction of cytotoxic T cells," The Journal of Immunology, vol. 141, no. 5, pp. 1543-1549, 1988.
33. F.Houssiau and J. van Snick, "IL6 and T-cell response," Research in Immunology, vol. 143, no. 7, pp. 740-743, 1992.
34. M. K. Crow, "Modification of accessory molecule signaling," Springer Seminars in Immunopathology, vol. 27, no. 4, pp. 409- 424, 2006.
35. S. Ghosh, M. J. May, and E. B. Kopp, "NF-kappaB and rel proteins: Evolutionarily conserved mediators of immune responses,"Annual Reviewof Immunology, vol. 16,no. 1, pp.225- 260, 1998.
36. S. Beinke and S. C. Ley, "Functions of NF-B1 and NF-B2 in immune cell biology," The Biochemical Journal, vol. 382, no. 2, pp. 393-409, 2004.
37. L.Martinez-Pomares and S. Gordon, "Antigen presentation the macrophage way," Cell, vol. 131, no. 4, pp. 641-643, 2007.
38. B. Acosta-Iborra, A. Elorza, I. M. Olazabal et al., "Macrophage oxygen sensingmodulates antigen presentation and phagocytic functions involving IFN-γ production through the HIF-1α transcription factor," The Journal of Immunology, vol. 182, no. 5, pp. 3155-3164, 2009.
39. E. F. Morand and M. Leech, "Macrophage migration inhibitory factor in rheumatoid arthritis," Frontiers in Bioscience, vol. 10, no. 1, pp. 12-22, 2005.
40. B. Stuhlmuller, U. Ungethum, S. Scholze et al., "Identification of known and novel genes in activated monocytes from patients with rheumatoid arthritis," Arthritis and Rheumatism, vol. 43, no. 4, pp. 775-790, 2000.
41. S. Moncada, R. M. J. Palmer, and E. A. Higgs, "Nitric oxide: physiology, pathophysiology, and pharmacology," Pharmacological Reviews, vol. 43, no. 2, pp. 109-142, 1991.
42. S. Moncada and D. A. Higgs, "The L-arginine-nitric oxide pathway,"The New England Journal ofMedicine, vol. 329, no. 27, pp. 2002-2012, 1993.